Idiopathic Thrombocytopenic Purpura
📧 Sign up to get email alerts when something new happens for Idiopathic Thrombocytopenic Purpura.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2017-09-18Clinical Trial Update: Therapy of Adults Affected by Idiopathic Thrombocytopenic Purpura With Dexamethasone [Phase 2, Phase 3]
Clinical trial update on dexamethasone therapy for adults with idiopathic thrombocytopenic purpura (ITP) reported in Phase 2/Phase 3.
-
CLINICAL_TRIALS trial_result · 2017-04-17Clinical Trial Update: EXTEND (Eltrombopag Extended Dosing Study) [Phase 3]
This clinical trial update reports the completion of the Phase 3 EXTEND study of eltrombopag (Promacta) for idiopathic thrombocytopenic purp…
-
CLINICAL_TRIALS trial_result · 2016-07-18Clinical Trial Update: Ig NextGen 10% in Idiopathic Thrombocytopenic Purpura (ITP) Patients [Phase 3]
A Phase 3 clinical trial evaluating Ig NextGen 10% for idiopathic thrombocytopenic purpura (ITP) has completed.
-
CLINICAL_TRIALS trial_result · 2016-04-20Clinical Trial Update: High-dose Dexamethasone Versus Conventional Dose Prednisone for Initial Treatment of Primary Immune Thrombocytopenia (ITP) [Phase 4]
Phase 4 trial comparing high-dose dexamethasone to conventional-dose prednisone for initial treatment of primary immune thrombocytopenia has…
-
CLINICAL_TRIALS trial_result · 2016-02-24Clinical Trial Update: Interventional Study in Adults With Immune Thrombocytopenia Purpura (ITP) Receiving Romiplostim [Phase 2]
A Phase 2 interventional trial in adults with immune thrombocytopenia purpura (idiopathic thrombocytopenic purpura) on romiplostim has compl…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2015-04-09Clinical Trial Update: Safety Study of GMA161 in Patients With Idiopathic Thrombocytopenic Purpura (ITP) [Phase 1]
A phase 1 safety study of GMA161 in patients with idiopathic thrombocytopenic purpura has been terminated.
-
CLINICAL_TRIALS trial_result · 2015-03-09Clinical Trial Update: Eltrombopag Phase III Study In Chinese Chronic ITP Patients [Phase 3]
Phase III trial update for eltrombopag in Chinese chronic idiopathic thrombocytopenic purpura (ITP) patients; results posted after completio…
-
CLINICAL_TRIALS trial_result · 2015-01-01Clinical Trial Update: Study on Bone Marrow Morphology in Adults Receiving Romiplostim for Treatment of Thrombocytopenia Associated With Immune Thrombocytopenia Purpura (ITP) [Phase 4]
A Phase 4 clinical trial update assessing bone marrow morphology in adults treated with romiplostim for thrombocytopenia associated with idi…
-
CLINICAL_TRIALS trial_result · 2014-10-31Clinical Trial Update: Efficacy and Safety Study of Eltrombopag in Pediatric Patients With Thrombocytopenia From Chronic Idiopathic Thrombocytopenic Purpura (ITP) [Phase 2]
Phase 2 trial assessing eltrombopag for efficacy and safety in pediatric patients with chronic idiopathic thrombocytopenic purpura (ITP).
-
CLINICAL_TRIALS trial_result · 2014-10-22Clinical Trial Update: A Study Evaluating the Addition of MabThera (Rituximab) to Standard Treatment in Patients With Idiopathic Thrombocytopenic Purpura (ITP) [Phase 3]
Phase 3 study evaluating adding rituximab (MabThera) to standard treatment in idiopathic thrombocytopenic purpura (ITP) has completed with r…
-
CLINICAL_TRIALS trial_result · 2014-09-29Clinical Trial Update: Study of a New Medication for Childhood Chronic Immune Thrombocytopenia (ITP), a Blood Disorder of Low Platelet Counts That Can Lead to Bruising Easily, Bleeding Gums, and/or Bleeding Inside the Body. [Phase 3]
Phase 3 trial in children with immune thrombocytopenia (Idiopathic Thrombocytopenic Purpura) evaluating a new medication has completed. Resu…
-
CLINICAL_TRIALS trial_result · 2013-12-25Clinical Trial Update: Hemostasis in Patients With Idiopathic Thrombocytopenic Purpura
A completed clinical trial (NCT01571349) from Samsung Medical Center evaluating hemostasis in patients with idiopathic thrombocytopenic purp…
-
CLINICAL_TRIALS trial_result · 2013-11-01Clinical Trial Update: A Study in Healthy Subjects to Evaluate Bioavailability of 4 Formulations of E5501 [Phase 1]
Phase 1 study in healthy subjects evaluating the bioavailability of four formulations of E5501; the trial has completed.
-
CLINICAL_TRIALS trial_result · 2013-07-08Clinical Trial Update: Romiplostim (AMG 531) Versus Medical Standard of Care for Immune (Idiopathic) Thrombocytopenic Purpura [Phase 3]
Phase 3 trial comparing romiplostim to standard of care in immune (idiopathic) thrombocytopenic purpura (ITP) has completed with results pos…
-
CLINICAL_TRIALS trial_result · 2013-05-03Clinical Trial Update: Helicobacter Pylori Infection in Children With Chronic Idiopathic Thrombocytopenic Purpura [Phase 4]
A Phase 4 trial evaluating Helicobacter pylori infection in children with chronic idiopathic thrombocytopenic purpura has completed.
-
CLINICAL_TRIALS trial_result · 2013-04-15Clinical Trial Update: SB-497115 (Oral Thrombopoietin Receptor Agonist) Versus Placebo In Adults With Refractory Immune Thrombocytopenic Purpura (ITP) [Phase 2]
A Phase 2 trial evaluating SB-497115, an oral thrombopoietin receptor agonist, versus placebo in adults with refractory immune thrombocytope…
-
CLINICAL_TRIALS trial_result · 2012-11-09Clinical Trial Update: Clinical Trial of Rituximab in Children and Adolescents With Chronic Idiopathic Thrombocytopenic Purpura (ITP) [Phase 1, Phase 2]
This clinical trial evaluated rituximab in children and adolescents with chronic idiopathic thrombocytopenic purpura (ITP) and has completed…
-
CLINICAL_TRIALS trial_result · 2012-04-20Clinical Trial Update: Platelet Function in Idiopathic Thrombocytopenic Purpura (ITP) Patients With Eltrombopag [Phase 4]
Phase 4 update on platelet function in Idiopathic Thrombocytopenic Purpura patients treated with eltrombopag. The study status is completed.
-
CLINICAL_TRIALS trial_result · 2012-03-19Clinical Trial Update: Eltrombopag Taste Testing in Healthy Adult Volunteers [Phase 1]
Phase 1 clinical trial update on eltrombopag involving taste testing in healthy adult volunteers, sponsored by GlaxoSmithKline.
-
CLINICAL_TRIALS trial_result · 2012-03-09Clinical Trial Update: Subject Variability in Two Lots of E5501 Administered to Fed and Fasted Healthy Subjects [Phase 1]
Phase 1 pharmacokinetic variability study evaluating two lots of E5501 administered to fed and fasted healthy subjects.
-
CLINICAL_TRIALS trial_result · 2012-02-13Clinical Trial Update: An Open Label Study of Romiplostim in Adult Thrombocytopenic Subjects With ITP [Phase 3]
Open-label Phase 3 trial of romiplostim in adults with immune thrombocytopenia (ITP) has completed with results posted.
-
CLINICAL_TRIALS trial_result · 2011-12-01Clinical Trial Update: Clinical Evaluation of Eltrombopag in Chronic Idiopathic Thrombocytopenic Purpura (ITP) [Phase 3]
Phase 3 trial evaluating eltrombopag for chronic idiopathic thrombocytopenic purpura (ITP) completed with results posted in 2011.
-
CLINICAL_TRIALS trial_result · 2011-03-01Clinical Trial Update: Safety and Efficacy Study of Romiplostim (AMG 531) to Treat ITP in Pediatric Subjects [Phase 1, Phase 2]
Phase 1/2 study evaluating safety and efficacy of romiplostim in pediatric idiopathic thrombocytopenic purpura completed; results posted in …
-
CLINICAL_TRIALS trial_result · 2011-01-13Clinical Trial Update: High Dose Dexamethasone Vs. Conventional Dose Prednisolone in Adult ITP [Phase 3]
A Phase 3 trial comparing high-dose dexamethasone with conventional-dose prednisolone in adults with idiopathic thrombocytopenic purpura has…
-
CLINICAL_TRIALS trial_result · 2010-12-10Clinical Trial Update: P3 Study to Evaluate Efficacy and Safety of AMG 531 in Thrombocytopenic Japanese Subjects With Immune (Idiopathic) Thrombocytopenic Purpura [Phase 3]
Phase 3 trial evaluating AMG 531 in thrombocytopenic Japanese patients with idiopathic thrombocytopenic purpura has completed with results p…